American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

AAFP Urges FDA to Expedite Final Rule on Cigarette Warnings

Academy Decries Lengthy Period Tobacco Companies Have to Comply

By News Staff

About 3 million Americans could start smoking before new requirements for cigarette warnings take effect, the AAFP said in a recent letter (2-page PDF; About PDFs) to the FDA. That's because the Family Smoking Prevention and Tobacco Control Act President Obama signed into law in 2009 allows manufacturers more than a year to comply with the new regulations.
Stock photo of man smoking a cigarette
The act requires, among other things, cigarette packages and advertisements to have larger and more visible graphic health warnings. Specifically, manufacturers will be required to devote half of the front and back panels of cigarette packages to the warnings.

But, although the law was enacted in June 2009, it wasn't until November 2010 that the FDA published a proposed rule (43-page PDF; About PDFs) to implement this provision of the law, the Academy pointed out in its Dec. 22 letter. At that time, the agency also unveiled 36 graphic images (5.28-MB Zip file; About Downloading) it was proposing for use in the warnings and invited the public to provide comments before Jan. 11.

According to the act, however, the cigarette warning provision does not become effective until 15 months after publication of a final rule.

Given the 17-month delay already experienced between enactment of the law and the issuance of a proposed rule for implementation, the Academy urged the FDA "to publish the final rule as expeditiously as possible."


Tobacco Regulations Widget. Flash Player 9 or above is required.
Tobacco Regulations Widget.
Flash Player 9 or above is required.

The letter also stated that although the AAFP "recognizes that 'fifteen months' is specified in the statutory language, we must also draw attention to the approximately $12.5 billion spent in 2006 by tobacco companies on advertising and promotion. As the proposed rule states, tobacco companies frequently employ large marketing and advertising experts. The tobacco industry is accustomed to continuously updating cigarette packaging and advertisements."

Therefore, the letter added, "AAFP feels an additional 15 months after publication of a final rule is an excessive amount of time for the tobacco industry to comply with these new requirements."

According to the Substance Abuse and Mental Health Services Administration, an estimated 6,600 Americans become new smokers every day. Thus, about 3 million people could become new smokers during the 15-month compliance period, the letter said.

Despite its criticism of the implementation timeline, the AAFP lauded the FDA for its proposed new graphic warnings, which include a photograph of a dead body in a coffin and another showing a cadaver on a morgue table.

"The use of these graphics and revised statements will help minimize tobacco use through the warnings' increased ability to communicate the many health risks attributable to cigarette smoking," said the Academy.

The AAFP also voiced support for a proposal that new warnings include information about specific tobacco cessation resources, such as the quitline number (800) QUIT-NOW. In addition, the Academy provided details about its Ask and Act tobacco cessation program, which encourages family physicians to ask all patients about tobacco use and then act to help them quit.

Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

AAFP, USPSTF Recommend Against Routine PSA Screening

Inadequate, Disordered Sleep Increases Diabetes Risk

Text Messaging Could Hike Vaccination Rates

Fluoroquinolones Tied to Greater Retinal Detachment Risk

Sanofi Announces DTaP Vaccine Shortage

AHRQ Resources Provide Ready Access to Research Data

Community-onset C. difficile Infections on the Rise

New FamilyDoctor.org Content Helps With Caring for Elderly

U.S. Measles Cases in 2011 Highest in 15 Years

FDA Warns of More Finasteride Side Effects

'Take-Back' Initiative Focuses on Destroying Unwanted Drugs

Bariatric Surgery May Help Combat Type 2 Diabetes

Certain Skin Products Tied to Mercury Poisoning

FDA Clarifies Citalopram Usage, Dosing Warnings

Veterans With PTSD at Heightened Risk for Opioid Abuse

ACP Releases Guideline on Type 2 Diabetes Management

Office Champions Seeking Applicants for Second Wave

Surgeon General Releases Report on Teen Smoking

USPSTF Issues Final Cervical Cancer Screening Recommendations

FDA Approves First Quadrivalent Influenza Vaccine

Survey: Physicians May Have Trouble Interpreting Cancer Statistics

AIM-HI Nutrition Questionnaire Can Open Dialogue

Statin, HIV/Hepatitis C Drug Interactions May Pose Risks

Statin Therapy Effective in Both Genders, Study Suggests

AAFP, CDC Announce Immunization Schedule Change

Family Physicians on Front Lines of Caring for Vets

ACIP Votes to Expand Tdap Recommendation

Recalled Oral Contraceptives Pose Pregnancy Risk

Studies Shed Light on Vaccine Side Effect Risks

Dosing Problems Prompt Recall of Infants' Tylenol Products

TB 'Superbug' Not Stateside Threat, Says FP

Adult Vaccination Coverage Remains Low, Says CDC

FDA Warns of Health Risk Tied to PPI Use

Study: PPI Does Not Routinely Improve Asthma Control

Recalled Oral Contraceptives Pose Pregnancy Risk

CDC to Fund 2D Vaccine Barcoding Pilot

2012 Immunization Schedules Reflect Multiple Changes

Study: Cognitive Decline Detected in Middle-aged Adults

CDC Toolkit Can Help Clinicians Fight Norovirus Infection

Patient-Centered Care Linked to Lower Mortality

Study: Inappropriate Cancer Screenings Continue

Novartis Manufacturing Plant Closes After Drug Mix-ups

FDA Announces Classwide REMS for TIRF Medications